Biomarkers, Belonging, and the Missing Data: why Trans & Nonbinary people with dementia must be part of the conversation – Authored by Dáithí Clayton
Summary As blood biomarkers become an increasingly important tool in Alzheimer’s diagnosis, they offer new opportunities for earlier detection, less invasive testing, and improved access to support. But an important question remains: who is represented in the data underpinning these advances? In this blog, Dáithí Clayton explores how discussions about diversity in dementia research must…
